相关实验视频

Updated: Jul 30, 2026

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

14.7K

一个罕见类型淋巴瘤的病例报告:血管免疫细胞T细胞淋巴瘤

Andreia S Machado1, Ana Catarina B Marques2, Antony Soares Dionísio1

  • 1Internal Medicine Department, Unidade Local de Saúde Ocidental, Hospital São Francisco Xavier, Lisbon, PRT.

Cureus
|July 5, 2024
PubMed
概括

血管免疫原性T细胞淋巴瘤 (AITL),一种罕见的非霍奇金淋巴瘤,表现为模糊的症状,延迟诊断. 这一案例凸显了识别AITL的挑战,影响了患者的治疗结果.

关键词:
血管免疫芽细胞T细胞淋巴瘤埃索诺菲利亚 (eosinophilia) 是一种淋巴腺病变 - 淋巴腺病变非霍奇金淋巴瘤 (non-hodgkin lymphoma) 是一种非霍奇金淋巴瘤.周围T细胞淋巴瘤

更多相关视频

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.3K
Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues07:17

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

1.1K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.